MEDICATION: Generic:___dutasteride__Trade:____Avodart

Classification (Therapeutic/Pharmacologic) Ther Class benign prostatic hyperplasia bph agents / Pharm Class androgen inhibitors
Indication: Management of the symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland (alone or with tamsulosin).
Action: Inhibits the enzyme 5-alpha-reductase, which is responsible for converting testosterone to its potent metabolite 5-alpha-dihydrotestosterone in the
prostate gland and other tissues. 5-Alpha-dihydrotestosterone is partly responsible for prostatic hyperplasia.
Most common side effects: decreased libido, ejaculation disorders, erectile dysfunction, testicular pain, testicular swelling, rash, urticarial, angioedema
Contraindications: Hypersensitivity; Cross-sensitivity with other 5-alpha-reductase inhibitors may occur; Women; Pedi: Children
Nursing Implications: Assess patient for symptoms of prostatic hyperplasia (urinary hesitancy, feeling of incomplete bladder emptying, interruption of
urinary stream, impairment of size and force of urinary stream, terminal urinary dribbling, straining to start flow, dysuria, urgency) before and
periodically during therapy.
Nursing
Course
Date
Pt.
Initials

Dosage,
frequency, route
per MD or NP
order
Dose
Appropriate?

Why is Client receiving

the drug? What is the
expected effect?

Nursing Assessment
Prior & Post
Administration

Unexpected Response to
Medication?
Significant learning
experience r/t this
medication?

Evaluation of Medication
Action

________
________
_______
_

_______
________

7/15/15

_______
_

Medication: Generic____________________________________________Trade_________________________________________________________
Nursing
Course
Date
Pt.
Initials

Dosage,
frequency, route
per MD or NP
order
Dose
Appropriate?

Why is Client receiving

the drug? What is the
expected effect?

Nursing Assessment
Prior & Post
Administration

Unexpected Response to
Medication?
Significant learning
experience r/t this
medication?

Evaluation of Medication
Action

________
________
_______
_

_______
________
_______
_

________
________
_______
_

7/15/15

_______
________
_______
_

7/15/15